Related Experiment Video
Updated: Jul 6, 2026

10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
[Primary central nervous system lymphoma--a single center experience]
Zdravko Mitrović1, Ivo Radman, Igor Aurer
1Zavod za hematologiju, Klinika za unutarnje bolesti Medicinskog fakulteta, KBC Zagreb..
Lijecnicki Vjesnik
|April 4, 2008
Summary
Primary CNS lymphoma (PCNSL) is rare. High-dose methotrexate showed promise in younger patients, but older adults with PCNSL face poor prognoses despite treatment.
Area of Science:
- Oncology
- Neurology
- Hematology
Context:
- Primary CNS lymphoma (PCNSL) is a rare extranodal non-Hodgkin's lymphoma.
- Limited data exists on treatment outcomes for PCNSL, particularly in specific patient demographics.
Purpose:
- To retrospectively analyze treatment outcomes for PCNSL patients.
- To evaluate the efficacy of high-dose methotrexate and other treatment modalities.
Summary:
- Twenty PCNSL patients were treated over eight years.
- 13 patients received high-dose methotrexate (4 g/m2); others had different chemotherapy or radiotherapy.
- Complete remission was 40%, and 2-year survival was 30%, with no treatment-related deaths.
Impact:
- High-dose methotrexate is effective for younger PCNSL patients (<60 years).
- Older PCNSL patients have a poor prognosis regardless of treatment.
- Findings inform treatment strategies and prognosis for PCNSL.
Related Concept Videos
Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Lymphoid Cells and Tissues
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...